This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

NET for SGBV Survivors in Eastern DR Congo

This study is currently recruiting participants.
See Contacts and Locations
Verified December 2016 by Anke Köbach, University of Konstanz
Sponsor:
Collaborator:
Vivo international e.V.
Information provided by (Responsible Party):
Anke Köbach, University of Konstanz
ClinicalTrials.gov Identifier:
NCT02989987
First received: December 6, 2016
Last updated: December 7, 2016
Last verified: December 2016
  Purpose
Throughout the last 10 years Narrative Exposure Therapy (NET) has evolved as one of the most effective, culturally sensitive trauma interventions. In the present study the effectiveness of NET delivered by trained health personnel in a sample of survivors of sexual and gender based violence (SGBV) who suffer from Posttraumatic Stress Disorder (PTSD) will be assessed. Structured baseline, 3 and 6 month follow up interviews will be administered to assess the main outcome measures PTSD and shame. The trial will take place in Goma, DR Congo, where SGBV and its sequelae has been a major problem.

Condition Intervention
Posttraumatic Stress Disorder Shame Behavioral: Narrative Exposure Therapy Behavioral: Social Support

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Narrative Exposure Therapy for Survivors of Sexual and Gender Based Violence in Eastern DR Congo

Resource links provided by NLM:


Further study details as provided by Anke Köbach, University of Konstanz:

Primary Outcome Measures:
  • PSS-I: Posttraumatic Stress Disorder symptom severity (sumscore and diagnosis) [ Time Frame: Change from baseline to 3 and 6 months post treatment ]
    PTSD Symptom Scale - Interview (PSS-I; Foa & Tolin, 2000)

  • SVQ: Severity of shame (sumscore) [ Time Frame: Change from baseline to 3 and 6 months post treatment ]
    Shame Variability Questionnaire (Brown, Rizvi & Linehan, unpublished)


Secondary Outcome Measures:
  • ShutD: Severity of Shutdown Dissociation Symptoms (sumscore) [ Time Frame: Change from baseline to 3 and 6 months post treatment ]
    Shutdown Dissociation Scale (Schalinski et al., 2015)

  • PHQ: Depression symptom severity (sumscore) [ Time Frame: Change in 3 and 6 months post treatment ]
    Patient Health Questionnaire - 9 (PHQ-9; Kroenke & Spitzer, 2002)

  • Functionality (sumscore) [ Time Frame: 3 and 6 months post treatment ]
    Local Functionality Index (LFI; Bass et al., 2013)


Estimated Enrollment: 160
Study Start Date: September 2016
Estimated Study Completion Date: February 2018
Estimated Primary Completion Date: August 2017 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Narrative Exposure Therapy
According to the NET manual (one lifeline session and 7 exposure sessions; see Schauer et al. 2011).
Behavioral: Narrative Exposure Therapy
Other Name: NET
Active Comparator: Treatment-as-usual
Social support (provided on demand)
Behavioral: Social Support
A local counselors provides social support on demand.

Detailed Description:
Participants will be recruited through local NGOs and eligible clients randomized to the treatment (NET; app. N=80) or treatment-as-usual control (app. N=80) group, respectively. At baseline, 3-month and 6-month post-treatment, sociodemographic data, trauma exposure - esp. SGBV, PTSD, dissociation, shame, functionality and depression will be assessed in a structured interview. The interviews will be conducted by blind Congolese psychological interviewers after an intensive 3-weeks training and continuous supervision.
  Eligibility

Ages Eligible for Study:   16 Years to 80 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • SGBV survivors (event happened more than 4 weeks ago)
  • PTSD diagnosis (DSM-5)

Exclusion Criteria:

  • Acute psychosis
  • Signs of cerebro-organic disease
  • Acute drug or alcohol intoxication
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02989987

Locations
Germany
University of Konstanz Recruiting
Konstanz, BW, Germany, 78464
Contact: Anke Koebach, Dr.    07531884626    anke.koebach@uni-konstanz.de   
Sponsors and Collaborators
University of Konstanz
Vivo international e.V.
  More Information

Publications:
Schauer, M., Schauer, M., Neuner, F., & Elbert, T. (2011). Narrative exposure therapy: A short-term treatment for traumatic stress disorders. Hogrefe Publishing.

Responsible Party: Anke Köbach, Postdoctoral Researcher, University of Konstanz
ClinicalTrials.gov Identifier: NCT02989987     History of Changes
Other Study ID Numbers: SGBV1617
Study First Received: December 6, 2016
Last Updated: December 7, 2016
Individual Participant Data  
Plan to Share IPD: Undecided

Keywords provided by Anke Köbach, University of Konstanz:
PTSD
Shame
Narrative Exposure Therapy
Sexual and gender based violence (SGBV)
DR Congo

Additional relevant MeSH terms:
Stress Disorders, Post-Traumatic
Stress Disorders, Traumatic
Trauma and Stressor Related Disorders
Mental Disorders

ClinicalTrials.gov processed this record on June 23, 2017